KRYS
Krystal Biotech Inc Earnings
$164.14
Earnings Summary
Revenue | $83.84Mn |
Net Profits | $27.18Mn |
Net Profit Margins | 32.42% |
Krystal Biotech Inc’s revenue jumped 879.91% since last year same period to $83.84Mn in the Q3 2024. On a quarterly growth basis, Krystal Biotech Inc has generated 19.29% jump in its revenue since last 3-months.
Krystal Biotech Inc’s net profit fell -66.34% since last year same period to $27.18Mn in the Q3 2024. On a quarterly growth basis, Krystal Biotech Inc has generated 74.59% jump in its net profits since last 3-months.
Krystal Biotech Inc’s net profit margin fell -96.56% since last year same period to 32.42% in the Q3 2024. On a quarterly growth basis, Krystal Biotech Inc has generated 46.36% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Krystal Biotech Inc post its latest quarter earningsEPS Estimate Current Quarter | 0.9 |
EPS Estimate Current Year | 0.9 |
Krystal Biotech Inc’s earning per share (EPS) estimates for the current quarter stand at 0.9 - a 55.17% jump from last quarter’s estimates.
Krystal Biotech Inc’s earning per share (EPS) estimates for the current year stand at 0.9.
Key Ratios
Key ratios of the Krystal Biotech Inc post its Q3 2024 earningsEarning Per Share (EPS) | 0.91 |
Krystal Biotech Inc’s earning per share (EPS) jumped 231.88% since last year same period to 0.91 in the Q3 2024. This indicates that the Krystal Biotech Inc has generated 231.88% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-08-05 | 0.58 | 0.53 | -8.62% |
2024-05-06 | 0.15 | 0.03 | -80% |
2024-11-04 | 0.9 | 0.91 | 1.11% |
₹0 US Stocks a/c Opening Fee